Effect of sipjeondaebo-tang on cancer-induced anorexia and cachexia in ct-26 tumor-bearing mice

Mediators of Inflammation

Volumn 2014, Issue , 2014, Pages

  Choi, Youn Kyung ^a   Jung, Ki Yong ^b   Woo, Sang Mi ^a   Yun, Yee Jin ^a   Jun, Chan Yong ^b   Park, Jong Hyeong ^b   Shin, Yong Cheol ^a   Cho, Sung Gook ^a   Ko, Seong Gyu ^a  

^a Kyung Hee University   (South Korea)

^b Gachon University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GASTROINTESTINAL HORMONE; GLUCAGON LIKE PEPTIDE 1; HEMOGLOBIN; HERBACEOUS AGENT; HORMONE; INTERLEUKIN 6; LEPTIN; MONOCYTE CHEMOTACTIC PROTEIN 1; PEPTIDE YY; SIPJEONDAEBO TANG; UNCLASSIFIED DRUG; CCL2 PROTEIN, MOUSE; GHRELIN; JUZENTAIHOTO; PLANT MEDICINAL PRODUCT; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANOREXIA; ARTICLE; CACHEXIA; CANCER INDUCED ANOREXIA; CONTROLLED STUDY; ERYTHROCYTE; FOOD INTAKE; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HERBAL MEDICINE; IN VIVO STUDY; MALE; MOUSE; MUSCLE MASS; NONHUMAN; TRADITIONAL MEDICINE; ANIMAL; BAGG ALBINO MOUSE; BLOOD; BODY WEIGHT; CANCER TRANSPLANTATION; COMPLICATION; INFLAMMATION; INTESTINE; METABOLISM; MUSCLE; NEOPLASMS; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; ANOREXIA; BODY WEIGHT; CACHEXIA; CELL LINE, TUMOR; CHEMOKINE CCL2; DRUGS, CHINESE HERBAL; GHRELIN; GLUCAGON-LIKE PEPTIDE 1; INFLAMMATION; INTERLEUKIN-6; INTESTINES; LEPTIN; MALE; MICE; MICE, INBRED BALB C; MUSCLES; NEOPLASM TRANSPLANTATION; NEOPLASMS; PEPTIDE YY; PLANT PREPARATIONS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84901812850     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2014/736563     Document Type: Article

References (51)

1. Dewys W. D., Begg C., Lavin P. T., Prognostic effect of weight loss prior to chemotherapy in cancer patients. The American Journal of Medicine 1980 69 4 491 497 2-s2.0-0018949428 (Pubitemid 10018703)
2. Brown J. K., A systematic review of the evidence on symptom management of cancer-related anorexia and cachexia. Oncology Nursing Forum 2002 29 3 517 532 2-s2.0-0036546077
3. Fearon K. C., Voss A. C., Hustead D. S., Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis. The American Journal of Clinical Nutrition 2006 83 6 1345 1350 2-s2.0-33745624014 (Pubitemid 44713065)
4. Ramos E. J. B., Suzuki S., Marks D., Inui A., Asakawa A., Meguid M. M., Cancer anorexia-cachexia syndrome: cytokines and neuropeptides. Current Opinion in Clinical Nutrition and Metabolic Care 2004 7 4 427 434 2-s2.0-14844320127 10.1097/01.mco.0000134363.53782.cb (Pubitemid 40340650)
5. Gordon J. N., Green S. R., Goggin P. M., Cancer cachexia. Monthly Journal of the Association of Physicians 2005 98 11 779 788 2-s2.0-27744507351 10.1093/qjmed/hci127 (Pubitemid 41631328)
6. Tisdale M. J., Cachexia in cancer patients. Nature Reviews Cancer 2002 2 11 862 871 2-s2.0-0036830917 10.1038/nrc927 (Pubitemid 37328904)
7. Fearon K. C. H., Moses A. G. W., Cancer cachexia. International Journal of Cardiology 2002 85 1 73 81 2-s2.0-0036342364 10.1016/S0167-5273(02)00235-8
8. Theologides A., Cancer cachexia. Cancer 1979 43 supplement 5 2004 2012 2-s2.0-0018773818 (Pubitemid 9200535)
9. Muscaritoli M., Bossola M., Aversa Z., Bellantone R., Rossi Fanelli F., Prevention and treatment of cancer cachexia: new insights into an old problem. European Journal of Cancer 2006 42 1 31 41 2-s2.0-29144513918 10.1016/j.ejca.2005.07.026 (Pubitemid 41814530)
10. Niwa K., Hashimoto M., Morishita S., Lian Z., Tagami K., Mori H., Tamaya T., Preventive effects of Juzen-taiho-to on N-methyl-N-nitrosourea and estradiol-17 β -induced endometrial carcinogenesis in mice. Carcinogenesis 2001 22 4 587 591 2-s2.0-0035075731 (Pubitemid 32288659)
11. Sawalha A. F., Sweileh W. M., Zyoud S. H., Jabi S. W., Self-therapy practices among university students in Palestine: focus on herbal remedies. Complementary Therapies in Medicine 2008 16 6 343 349 2-s2.0-56349084198 10.1016/j.ctim.2007.12.002
12. Matsumoto T., Sakurai M. H., Kiyohara H., Yamada H., Orally administered decoction of Kampo (Japanese herbal) medicine, "Juzen-Taiho-To" modulates cytokine secretion and induces NKT cells in mouse liver. Immunopharmacology 2000 46 2 149 161 2-s2.0-0033985502 10.1016/S0162-3109(99) 00166-6 (Pubitemid 30019256)
13. Saiki I., A Kampo medicine "Juzen-taiho-to"-prevention of malignant progression and metastasis of tumor cells and the mechanism of action. Biological and Pharmaceutical Bulletin 2000 23 6 677 688 2-s2.0-0033943563 (Pubitemid 30435069)
14. Utsuyama M., Seidlar H., Kitagawa M., Hirokawa K., Immunological restoration and anti-tumor effect by Japanese herbal medicine in aged mice. Mechanisms of Ageing and Development 2001 122 3 341 352 2-s2.0-0035047022 10.1016/S0047-6374(00)00249-9 (Pubitemid 32322449)
15. Haranaka R., Hasegawa R., Nakagawa S., Sakurai A., Satomi N., Haranaka K., Antitumor activity of combination therapy with traditional Chinese medicine and OK432 or MMC. Journal of Biological Response Modifiers 1988 7 1 77 90 2-s2.0-0023832988 (Pubitemid 18037433)
16. Sugiyama K., Ueda H., Ichio Y., Yokota M., Improvement of cisplatin toxicity and lethality by Juzen-taiho-to in mice. Biological and Pharmaceutical Bulletin 1995 18 1 53 58 2-s2.0-0028855134
17. Onishi Y., Yamaura T., Tauchi K., Sakamoto T., Tsukada K., Nunome S., Komatsu Y., Saiki I., Expression of the anti-metastatic effect induced by Juzen-taiho-to is based on the content of Shimotsu-to constituents. Biological and Pharmaceutical Bulletin 1998 21 7 761 765 2-s2.0-0031858468 (Pubitemid 28374454)
18. Ohnishi Y., Fujii H., Kimura F., Mishima T., Murata J., Tazawa K., Fujimaki M., Okada F., Hosokawa M., Saiki I., Inhibitory effect of a traditional Chinese medicine, Juzen-taiho-to, on progressive growth of weakly malignant clone cells derived from murine fibrosarcoma. Japanese Journal of Cancer Research 1996 87 10 1039 1044 (Pubitemid 26392040)
19. Ohnishi Y., Fujii H., Hayakawa Y., Sakukawa R., Yamaura T., Sakamoto T., Tsukada K., Fujimaki M., Nunome S., Komatsu Y., Saiki I., Oral administration of a Kampo (Japanese herbal) medicine Juzen-taiho-to inhibits liver metastasis of colon 26-L5 carcinoma cells. Japanese Journal of Cancer Research 1998 89 2 206 213 2-s2.0-15144345056 (Pubitemid 28143449)
20. Aulino P., Berardi E., Cardillo V. M., Rizzuto E., Perniconi B., Ramina C., Padula F., Spugnini E. P., Baldi A., Faiola F., Adamo S., Coletti D., Molecular, cellular and physiological characterization of the cancer cachexia-inducing C26 colon carcinoma in mouse. BMC Cancer 2010 10 article 363 2-s2.0-77955388009 10.1186/1471-2407-10-363
21. Tisdale M. J., Mechanisms of cancer cachexia. Physiological Reviews 2009 89 2 381 410 2-s2.0-67649982995 10.1152/physrev.00016.2008
22. Michalak S., Wender M., Michałowska-Wender G., Cachexia-induced cerebellar degeneration: involvement of serum TNF and MCP-1 in the course of experimental neoplastic disease. Acta Neurobiologiae Experimentalis 2006 66 2 113 122 2-s2.0-33746443796 (Pubitemid 44124950)
23. Havel P. J., Peripheral signals conveying metabolic information to the brain: short-term and long-term regulation of food intake and energy homeostasis. Experimental Biology and Medicine 2001 226 11 963 977 2-s2.0-0035758109
24. Le Roux C. W., Aylwin S. J. B., Batterham R. L., Borg C. M., Coyle F., Prasad V., Shurey S., Ghatei M. A., Patel A. G., Bloom S. R., Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Annals of Surgery 2006 243 1 108 114 2-s2.0-30144444692 10.1097/01.sla.0000183349.16877.84 (Pubitemid 43054062)
25. Dhanapal R., Saraswathi T. R., Govind Rajkumar N., Cancer cachexia. Journal of Oral and Maxillofacial Pathology 2011 15 3 257 260 2-s2.0-81555214608 10.4103/0973-029X.86670
26. Bedi M. K., Shenefelt P. D., Herbal therapy in dermatology. Archives of Dermatology 2002 138 2 232 242 2-s2.0-0036172374 (Pubitemid 34160399)
27. Olaku O., White J. D., Herbal therapy use by cancer patients: a literature review on case reports. European Journal of Cancer 2011 47 4 508 514 2-s2.0-79851510937 10.1016/j.ejca.2010.11.018
28. Yin S. Y., Wei W. C., Jian F. Y., Yang N. S., Therapeutic applications of herbal medicines for cancer patients. Evidence-Based Complementary and Alternative Medicine 2013 2013 15 302426 10.1155/2013/302426
29. Hisha H., Yamada H., Sakurai M. H., Kiyohara H., Li Y., Yu C., Takemoto N., Kawamura H., Yamaura K., Shinohara S., Komatsu Y., Aburada M., Ikehara S., Isolation and identification of hematopoietic stem cell-stimulating substances from Kampo (Japanese herbal) medicine, Juzen-taiho-to. Blood 1997 90 3 1022 1030 (Pubitemid 27314136)
30. Mantovani G., Macciò A., Madeddu C., Mura L., Massa E., Mudu M., Mulas C., Lusso M., Gramignano G., Piras M., Serum values of proinflammatory cytokines are inversely correlated with serum leptin levels in patients with advanced stage cancer at different sites. Journal of Molecular Medicine 2001 79 7 406 414 2-s2.0-0034921436 10.1007/s001090100234 (Pubitemid 32692637)
31. Catalano M. G., Fortunati N., Arena K., Costelli P., Aragno M., Danni O., Boccuzzi G., Selective up-regulation of tumor necrosis factor receptor I in tumor-bearing rats with cancer-related cachexia. International Journal of Oncology 2003 23 2 429 436 2-s2.0-1542602172
32. Scott H. R., McMillan D. C., Crilly A., McArdle C. S., Milroy R., The relationship between weight loss and interleukin 6 in non-small-cell lung cancer. The British Journal of Cancer 1996 73 12 1560 1562 (Pubitemid 26235384)
33. Moses A. G. W., Maingay J., Sangster K., Fearon K. C. H., Ross J. A., Pro-inflammatory cytokine release by peripheral blood mononuclear cells from patients with advanced pancreatic cancer: relationship to acute phase response and survival. Oncology Reports 2009 21 4 1091 1095 2-s2.0-67449088926 10.3892/or-00000328
34. Hong D. S., Angelo L. S., Kurzrock R., Interleukin-6 and its receptor in cancer: implications for translational therapeutics. Cancer 2007 110 9 1911 1928 2-s2.0-35648995976 10.1002/cncr.22999 (Pubitemid 350036849)
35. Wolf I., Sadetzki S., Kanely H., Kundel Y., Pariente C., Epstein N., Oberman B., Catane R., Kaufman B., Shimon I., Adiponectin, ghrelin, and leptin in cancer cachexia in breast and colon cancer patients. Cancer 2006 106 4 966 973 2-s2.0-32544440799 10.1002/cncr.21690 (Pubitemid 43238466)
36. Dicato M., Plawny L., Diederich M., Anemia in cancer. Annals of Oncology 2010 21 supplement 7 vii167 vii172 2-s2.0-78649362425 10.1093/annonc/mdq284
37. Glaspy J., Degos L., Dicato M., Demetri G. D., Comparable efficacy of epoetin alfa for anemic cancer patients receiving platinum- and nonplatinum-based chemotherapy: a retrospective subanalysis of two large, community-based trials. Oncologist 2002 7 2 126 135 2-s2.0-0036224630 10.1634/theoncologist.7-2-126 (Pubitemid 34438541)
38. Cone R. D., Anatomy and regulation of the central melanocortin system. Nature Neuroscience 2005 8 5 571 578 2-s2.0-17844401704 10.1038/nn1455 (Pubitemid 40594196)
39. Rolls E. T., Smell, taste, texture, and temperature multimodal representations in the brain, and their relevance to the control of appetite. Nutrition Reviews 2004 62 11 S193 S204 2-s2.0-9444259265 10.1301/nr.2004.nov. S193-S204 (Pubitemid 39564805)
40. Inui A., Feeding and body-weight regulation by hypothalamic neuropeptides-mediation of the actions of leptin. Trends in Neurosciences 1999 22 2 62 67 2-s2.0-0033082426 10.1016/S0166-2236(98)01292-2 (Pubitemid 29125552)
41. Sonti G., Ilyin S. E., PlataSalaman C. R., Anorexia induced by cytokine interactions at pathophysiological concentrations. The American Journal of Physiology: Regulatory Integrative and Comparative Physiology 1996 270 6, part 2 R1394 R1402
42. Moldawer L. L., Rogy M. A., Lowry S. F., The role of cytokines in cancer cachexia. Journal of Parenteral and Enteral Nutrition 1992 16 supplement 6 43S 49S 2-s2.0-0026470961
43. MacDonald N., Easson A. M., Mazurak V. C., Dunn G. P., Baracos V. E., Understanding and managing cancer cachexia. Journal of the American College of Surgeons 2003 197 1 143 161 2-s2.0-0038310898 10.1016/S1072-7515(03)00382-X (Pubitemid 36759189)
44. Plata-Salamán C. R., Ilyin S. E., Gayle D., Brain cytokine mRNAs in anorectic rats bearing prostate adenocarcinoma tumor cells. The American Journal of Physiology: Regulatory Integrative and Comparative Physiology 1998 275 2 R566 R573 2-s2.0-0031844188
45. Gerhardt C. C., Romero I. A., Cancello R., Camoin L., Strosberg A. D., Chemokines control fat accumulation and leptin secretion by cultured human adipocytes. Molecular and Cellular Endocrinology 2001 175 1-2 81 92 2-s2.0-0035946468 10.1016/S0303-7207(01)00394-X (Pubitemid 32372545)
46. Ishibashi Y., Nishino Y., Matsui T., Takeuchi M., Yamagishi S. I., Glucagon-like peptide-1 suppresses advanced glycation end product-induced monocyte chemoattractant protein-1 expression in mesangial cells by reducing advanced glycation end product receptor level. Metabolism: Clinical and Experimental 2011 60 9 1271 1277 2-s2.0-80051800781 10.1016/j.metabol.2011.01. 010
47. Kihira Y., Miyake M., Hirata M., Deletion of hypoxia-inducible factor-1alpha in adipocytes enhances glucagon-like Peptide-1 secretion and reduces adipose tissue inflammation. PLoS ONE 2014 9 4 e93856 10.1371/journal.pone.0093856
48. Shirazi R., Palsdottir V., Collander J., Glucagon-like peptide 1 receptor induced suppression of food intake, and body weight is mediated by central IL-1 and IL-6. Proceedings of the National Academy of Sciences of the United States of America 2013 110 40 16199 16204 10.1073/pnas.1306799110
49. Lee Y. S., Park M. S., Choung J. S., Glucagon-like peptide-1 inhibits adipose tissue macrophage infiltration and inflammation in an obese mouse model of diabetes. Diabetologia 2012 55 9 2456 2468 10.1007/s00125-012-2592-3
50. Ellingsgaard H., Hauselmann I., Schuler B., Habib A. M., Baggio L. L., Meier D. T., Eppler E., Bouzakri K., Wueest S., Muller Y. D., Hansen A. M. K., Reinecke M., Konrad D., Gassmann M., Reimann F., Halban P. A., Gromada J., Drucker D. J., Gribble F. M., Ehses J. A., Donath M. Y., Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells. Nature Medicine 2011 17 11 1481 1489 2-s2.0-81255157471 10.1038/nm.2513
51. Garcia J. M., Garcia-Touza M., Hijazi R. A., Taffet G., Epner D., Mann D., Smith R. G., Cunningham G. R., Marcelli M., Active ghrelin levels and active to total ghrelin ratio in cancer-induced cachexia. Journal of Clinical Endocrinology and Metabolism 2005 90 5 2920 2926 2-s2.0-18844441671 10.1210/jc.2004-1788 (Pubitemid 40686344)